Literature DB >> 3236357

Counselling for prenatal diagnosis of sickle cell disease and beta thalassaemia major: a four year experience.

E N Anionwu1, N Patel, G Kanji, H Renges, M Brozović.   

Abstract

A non-directive programme of prenatal counselling was used during a four year period. Forty-three couples at risk for having a baby with a haemoglobinopathy were identified. Prenatal diagnosis was offered in 19 pregnancies to 14 couples at risk of having a baby with sickle cell anaemia and in two pregnancies in two couples at risk of a baby with beta thalassaemia major, who presented before the 18th week of pregnancy. Six couples at risk for sickle cell anaemia accepted prenatal diagnosis in 10 pregnancies, as did both couples at risk for thalassaemia. Couples who were eligible for prenatal diagnosis but refused it tended not to have been informed about sickle cell disease before counselling, one partner was more frequently absent at the time of the initial counselling session, or they either had no children with sickle cell disease or the children were not severely affected. Other factors influencing their decision included a poor obstetric history and rejection of abortion, mainly on moral grounds. The approximately 50% uptake of prenatal diagnosis in this initial study highlights the complex issues involved. Our experience indicates that with systematic screening and counselling in the antenatal clinic, and with increased awareness of the haemoglobinopathies, couples at risk will be in a better position to make informed decisions.

Entities:  

Mesh:

Year:  1988        PMID: 3236357      PMCID: PMC1051583          DOI: 10.1136/jmg.25.11.769

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  3 in total

Review 1.  Prenatal diagnosis of the common haemoglobin disorders.

Authors:  D J Weatherall; J M Old; S L Thein; J S Wainscoat; J B Clegg
Journal:  J Med Genet       Date:  1985-12       Impact factor: 6.318

2.  Special considerations for minority participation in prenatal diagnosis.

Authors:  R F Murray; N Chamberlain; J Fletcher; E Hopkins; R Jackson; P A King; T M Powledge
Journal:  JAMA       Date:  1980-03-28       Impact factor: 56.272

3.  Sickle cell disease in Britain.

Authors:  M Brozović; E Anionwu
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

  3 in total
  5 in total

1.  Genetic screening for ethnic minorities.

Authors:  M Modell; B Modell
Journal:  BMJ       Date:  1990-06-30

2.  Prenatal diagnosis of sickle cell disease by the technique of PCR.

Authors:  Praneeta J Singh; A C Shrivastava; A V Shrikhande
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-08       Impact factor: 0.900

3.  Contraceptives, counselling, and pregnancy in women with sickle cell disease.

Authors:  R J Howard; C Lillis; S M Tuck
Journal:  BMJ       Date:  1993-06-26

4.  Factors affecting the uptake of prenatal diagnosis for sickle cell disease.

Authors:  M Petrou; M Brugiatelli; R H Ward; B Modell
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

5.  Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.